Radius Health Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis Drug

CAMBRIDGE, MA -- (Marketwire) -- 03/12/13 -- ("Radius"), a biopharmaceutical company focused on developing new therapeutics…

Continue Reading